Skip to content
Search

Latest Stories

Coeliac UK raises ‘grave concerns’ over withdrawal of gluten free prescriptions in West Yorkshire

Coeliac UK raises ‘grave concerns’ over withdrawal of gluten free prescriptions in West Yorkshire

The charity has urged the ICB to reconsider their policy which poses an additional challenge for people living with the condition

NHS West Yorkshire Integrated Care Board (ICB)’s decision to withdraw gluten free prescriptions for people with coeliac disease across Leeds and Calderdale has disappointed Coeliac UK.


In a statement released on Thursday, the charity, which provides support and advice to those living with the disease, has raised “grave concerns” about the decision, warning that it will have a detrimental impact on the coeliac community.

The policy is currently implemented across the ICB’s other places including Bradford district and Craven, Kirklees and Wakefield district, preventing coeliac patients from accessing gluten free bread and flour mix on prescription.

NHS West Yorkshire ICB wants to align its gluten free prescribing guidelines across its five places.

But the charity is worried that the additional cost of gluten free staple products will poses a real challenge to maintaining the gluten-free diet, which is the only treatment for the condition.

A study by the charity last year found that a weekly gluten free food shop can be 20 per cent more expensive than a standard weekly food shop. Further, the report revealed that the cheapest loaf of gluten free bread cost 7.2 times more than the cheapest gluten containing loaf.

Tristan Humphreys, Head of Advocacy, Coeliac UK, said: “We are extremely disappointed that NHS West Yorkshire ICB has taken this decision. These changes remove a much-needed lifeline for those with coeliac disease in Leeds and Calderdale at a time when the cost-of-living crisis is hitting people with coeliac disease particularly hard.

“Failure to support people with coeliac disease risks them developing serious long-term conditions down the line, the cost of which overshadows that of gluten free prescriptions,” he added.

According to Humphreys, the ICB has failed to provide any evidence to support their claims that there has not been any adverse impact on the places that previously withdrew gluten free prescribing.

Hence, Coeliac UK has urged the ICB to reconsider this policy and “do the right thing, based on the evidence.”

The charity suggested that West Yorkshire should follow the footsteps of neighbouring NHS South Yorkshire ICB which has adopted a policy of gluten free prescribing for health equality grounds.

Sue Johnson

Picture: Sue Johnson

The withdrawal of gluten free prescriptions has come as a big blow to Sue Johnson, a coeliac patient from Leeds, who is already struggling to secure gluten free food due to inflation.

She said: “I was diagnosed with coeliac disease when I was in my forties and I shall be 77 this year. If I consume gluten I have very severe symptoms. Within an hour, I feel faint and dizzy and need to lie down. Following that, I'm repeatedly violently sick and experience bouts of diarrhoea, alongside painful cramps which can last for days.

“I have struggled to pay my gas and electricity bills over the last year, all made worse by higher food prices. This will only get more difficult, without access to gluten free bread and flour on prescription.

“Gluten free food is my medicine. I feel really let down by the ICB, who don’t seem to understand the reality for people living with coeliac disease,” she added.

While patients can opt for gluten free substitute foods such rice and potatoes, there are practical challenges for food on the go, packed lunches, additional preparation requirements and energy costs for cooking, the charity noted.

Coeliac disease is an autoimmune disorder in which the immune system mistakenly recognizes gluten (a protein found in wheat, barley, and rye) as "foreign" and causes chronic inflammation in the small intestine, and lead to bloating, stomach cramps, vomiting, diarrhoea and tiredness.

Patients are also at risk of developing osteoporosis, neurological dysfunction, unexplained infertility, recurrent miscarriage and in rare cases even small bowel cancer.

 

More For You

Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less